124 related articles for article (PubMed ID: 17037411)
1. [Two lung adenocarcinoma patients with multiple brain metastasis treated with Gefitinib and surviving more than 2 years].
Matsuyama W; Yamamoto M; Machida K; Mitsuyama H; Watanabe M; Higashimoto I; Osame M; Arimura K
Nihon Kokyuki Gakkai Zasshi; 2006 Sep; 44(9):653-8. PubMed ID: 17037411
[TBL] [Abstract][Full Text] [Related]
2. [A case of complete response in a primary lesion treated by gefitinib for two years after surgery of brain metastasis from lung cancer].
Matsuoka T; Morikage N; Kuga T; Nakayama T; Fujii Y
Gan To Kagaku Ryoho; 2006 Apr; 33(4):497-500. PubMed ID: 16612160
[TBL] [Abstract][Full Text] [Related]
3. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
[TBL] [Abstract][Full Text] [Related]
4. [Two cases of meningeal carcinomatosis during gefitinib therapy for non-small cell lung cancer].
Abe T; Hayashi M; Tsutsui N; Ito K; Haraguchi M
Nihon Kokyuki Gakkai Zasshi; 2006 Feb; 44(2):144-9. PubMed ID: 17228810
[TBL] [Abstract][Full Text] [Related]
5. Total regression of brain metastases in non-small cell lung cancer patients harboring EGFR mutations treated with gefitinib without radiotherapy: two case reports.
Chonan M; Narita N; Tominaga T
BMC Res Notes; 2016 Jan; 9():2. PubMed ID: 26724810
[TBL] [Abstract][Full Text] [Related]
6. Brain metastases in metastatic non-small cell lung cancer responding to single-agent gefitinib: a case report.
Stemmler HJ; Weigert O; Krych M; Schoenberg SO; Ostermann H; Hiddemann W
Anticancer Drugs; 2005 Aug; 16(7):747-9. PubMed ID: 16027524
[TBL] [Abstract][Full Text] [Related]
7. [Successful gefitinib every other day administration in an advanced lung cancer patient with brain metastasis after gamma knife radiotherapy and chemotherapy].
Tomisaki S; Takenaka T; Morizono G; Tanaka T; Momosaki N; Inoue F
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2607-10. PubMed ID: 20009463
[TBL] [Abstract][Full Text] [Related]
8. [A case of postoperative recurrent lung cancer with long survival due to gefitinib efficacy].
Okagawa T; Uchida T; Suyama M
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1841-3. PubMed ID: 18030020
[TBL] [Abstract][Full Text] [Related]
9. [A case of lung adenocarcinoma of the lung with disappearance of brain metastasis by re-treatment with gefitinib].
Kato T; Nakashima M; Yoshimura K; Imao M; Goto H; Yasuda S; Sano K
Nihon Kokyuki Gakkai Zasshi; 2005 Nov; 43(11):700-3. PubMed ID: 16366371
[TBL] [Abstract][Full Text] [Related]
10. [Recurrence of non-small cell lung cancer after successful treatment with gefitinib--report of three cases].
Hoshi S; Yamaguchi T; Kono C; Amano H; Yamada Y
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1209-13. PubMed ID: 15332545
[TBL] [Abstract][Full Text] [Related]
11. Gefitinib as palliative therapy for lung adenocarcinoma metastatic to the brain.
Wu C; Li YL; Wang ZM; Li Z; Zhang TX; Wei Z
Lung Cancer; 2007 Sep; 57(3):359-64. PubMed ID: 17434236
[TBL] [Abstract][Full Text] [Related]
12. [Complete remission of multiple brain metastases of non-small cell lung cancer induced by gefitinib monotherapy].
Müller F; Riesenberg H; Hirnle P; Gehl HB; Düwel P; Görner M
Strahlenther Onkol; 2011 Dec; 187(12):826-30. PubMed ID: 22127359
[TBL] [Abstract][Full Text] [Related]
13. Dramatic responses to gefitinib when used as front line therapy in two cases of metastatic lung adenocarcinoma with poor performance status.
Gupta A; Raina V; Garg P; Kumar R
J Cancer Res Ther; 2010; 6(3):362-4. PubMed ID: 21119278
[TBL] [Abstract][Full Text] [Related]
14. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib.
Katayama T; Shimizu J; Suda K; Onozato R; Fukui T; Ito S; Hatooka S; Sueda T; Hida T; Yatabe Y; Mitsudomi T
J Thorac Oncol; 2009 Nov; 4(11):1415-9. PubMed ID: 19692934
[TBL] [Abstract][Full Text] [Related]
16. First-line systemic treatment with gefitinib in stage IV non-small cell lung cancer.
Lange T; Müller-Tidow C; Serve H; Hoffknecht P; Berdel WE; Thomas M
Oncol Rep; 2005 Dec; 14(6):1539-42. PubMed ID: 16273252
[TBL] [Abstract][Full Text] [Related]
17. High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib.
Omuro AM; Kris MG; Miller VA; Franceschi E; Shah N; Milton DT; Abrey LE
Cancer; 2005 Jun; 103(11):2344-8. PubMed ID: 15844174
[TBL] [Abstract][Full Text] [Related]
18. Effect of gefitinib on brain metastases from non-small cell lung cancer.
Nishi N; Kawai S; Yonezawa T; Fujimoto K; Masui K
Neurol Med Chir (Tokyo); 2006 Oct; 46(10):504-7. PubMed ID: 17062991
[TBL] [Abstract][Full Text] [Related]
19. Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer.
Yokouchi H; Yamazaki K; Kinoshita I; Konishi J; Asahina H; Sukoh N; Harada M; Akie K; Ogura S; Ishida T; Munakata M; Dosaka-Akita H; Isobe H; Nishimura M
BMC Cancer; 2007 Mar; 7():51. PubMed ID: 17374153
[TBL] [Abstract][Full Text] [Related]
20. Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity.
Chiu CH; Tsai CM; Chen YM; Chiang SC; Liou JL; Perng RP
Lung Cancer; 2005 Jan; 47(1):129-38. PubMed ID: 15603863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
